by Prostate Cancer Center | Nov 13, 2026 | Prostate Cancer
As rates of advanced prostate cancer continue to rise, the American Cancer Society made important changes to their prostate cancer screening guidelines: Men 50 to 69 should get a PSA test every two years; Black men and men with a family history of prostate cancer...
by Prostate Cancer Center | Oct 3, 2026 | Improved CyberKnife Technology Improves Patient Outcomes
Madison, Wis. — Accuray, the manufactuer of CyberKnife Radition Therapy has entered into agreements with Samsung HME America, doing business as NeuroLogica Corp., to pursue advanced volumetric imaging capabilities for the CyberKnife System. The companies announced...
by Prostate Cancer Center | Sep 30, 2026 | CyberKnife vs Surgery for Prostate Cancer
For John, staying active has always been an important part of life. He enjoys being outdoors, working around his rural property. So, when he was diagnosed with prostate cancer, finding a treatment option that aligned with his lifestyle and his evidence-based approach...
by Prostate Cancer Center | Sep 27, 2026 | Impressive New Research on CyberKnife for Prostate Cancer
Dr. Robert Meier, Radiation Oncology Medical Director at Swedish Radiosurgery Center is the principal investigator on a breakthrough study published in European Urology, a leading international journal and one of the most influential publications in the field of...
by Prostate Cancer Center | Sep 27, 2026 | Prostate Cancer Stages 1 to 4
Staging of prostate cancer, or any cancer for that matter, is a detailed way to describe how much disease is in the body when the cancer is diagnosed, according to the American Cancer Society. It’s just one factor doctors use to determine how to treat the cancer. The...
Recent Comments